Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Upadacitinib effectively treated severe hair loss in a child.

Baricitinib may effectively treat oral lichen planus.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Erlotinib can cause hair loss as a side effect.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

A woman's hair turned white after taking a cancer drug called dasatinib.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Topical Ruxolitinib may safely treat severe hair loss.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Gefitinib can cause rare scarring hair loss.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.